• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canada’s Drug Agency (CDA-AMC)
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Regione Emilia Romagna
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Canada
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [3358 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2010     Medical Advisory Secretariat (MAS) Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer : an evidence-based and economic analysis
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Sternal talon for cardiac surgery patients: a review of the clinical effectiveness and guidelines
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Protein-sparing modified fast diet: efficacity, safety and clinical use - literature review]
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Tinnitus retraining therapy: a review of the clinical effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Pre-hospital phlebotomy for patients with urgent conditions: a review of the clinical effectiveness and guidelines
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [External evaluation of cancer care organization and delivery: review of experiences relevant to the cancer team evaluation and designation process in Québec]
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Laser refractive surgery in children: a review of the clinical effectiveness and guidelines
2010     Institute of Health Economics (IHE) Sexual exploitation of children and youth over the internet: a rapid review of the scientific literature
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Laparoscopic sleeve gastrectomy: a review of the clinical benefits and harms
2010     Institute of Health Economics (IHE) Treatment for convicted adult male sex offenders
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Filtered needles for withdrawing medication from glass ampoules: a review of the cost-effectiveness and incidence of complications
2010     Institute of Health Economics (IHE) Means restriction for suicide prevention
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Periodontal regenerative procedures for patients with periodontal disease: a review of clinical effectiveness
2010     Institute of Health Economics (IHE) Telehealth in substance abuse and addiction: review of the literature on smoking, alcohol, drug abuse and gambling
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Completely-in-the-canal and bone anchored hearing aids: a review of the clinical effectiveness and cost-effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Critical incident stress debriefing for first responders: a review of the clinical benefit and harm
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Cognitive behavioural therapy for patients with addictions: a review of the clinical and cost-effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Atypical antipsychotics for the treatment of schizophrenia: a review of combination therapy and high-dosing strategies
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Tramadol compared with opioids for pain: a review of addiction potential
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Percutaneous heart valve replacement for valvular heart disease: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Cognitive behavioural therapy for post traumatic stress disorder: a review of the clinical and cost-effectiveness
2010     Medical Advisory Secretariat (MAS) Extracorporeal lung support technologies - bridge to recovery and bridge to lung transplantation in adult patients: an evidence-based analysis
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Rituximab for non-hodgkin's lymphoma: a review of the clinical and cost- effectiveness and guidelines
2010     Medical Advisory Secretariat (MAS) Solid organ transplantation for End Stage Organ Failure (ESOF) in persons with HIV
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of antipsychotics and/or benzodiazepines as rapid tranquilization in inpatients of mental facilities and emergency departments: a review of the clinical effectiveness and guidelines
2010     Medical Advisory Secretariat (MAS) Endovascular laser treatment for varicose veins
2010     Medical Advisory Secretariat (MAS) CT and MRI scans in the evaluation of chronic headaches
2010     Medical Advisory Secretariat (MAS) Cancer screening with digital mammography for women at average risk of breast cancer or MRI for women at high risk
2010     Medical Advisory Secretariat (MAS) Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analaysis
2010     Technology Assessment at SickKids (TASK) Health technology assessment of thiopurine methyltransferase testing for guiding 6-mercaptopurine doses in pediatric patients with acute lymphoblastic leukemia
2010     Technology Assessment at SickKids (TASK) The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis
2010     Medical Advisory Secretariat (MAS) The relative cost-effectiveness of five non-invasive cardiac imaging technologies for diagnosing coronary artery disease in Ontario
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Population ultrasound screening for abdominal aortic aneurysms]
2010     Institute of Health Economics (IHE) Evidence on the effectiveness of telerehabilitation applications
2010     Medical Advisory Secretariat (MAS) Use of contrast agents with echocardiography in patients with suboptimal echocardiography
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Cost-benefits evaluation of prevention and control of nosocomial MRSA infections]
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Proton therapy]
2010     Medical Advisory Secretariat (MAS) Negative pressure wound therapy: an evidence update
2010     Institute for Clinical Evaluative Sciences (ICES) Ontario Burden of Infectious Disease Study (ONBOIDS)
2010     Institute for Clinical Evaluative Sciences (ICES) Aging in Ontario: an ICES chartbook of health service use by older adults
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Clopidogrel versus other antiplatelet agents for secondary prevention of vascular events in adults with acute coronary syndrome or peripheral vascular disease: clinical and cost-effectiveness analyses
2010     Institute for Clinical Evaluative Sciences (ICES) How many Canadians will be diagnosed with diabetes between 2007 and 2017? Assessing population risk
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-emergency telecardiology consultation services: rapid review of clinical and cost outcomes
2010     Institute for Clinical Evaluative Sciences (ICES) Ontario Stroke Evaluation Report 2010: Technical Report.
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Teledermatology services: rapid review of diagnostic, clinical management, and economic outcomes
2010     Institute for Clinical Evaluative Sciences (ICES) Development of a consensus on evidence-based quality of care indicators for Canadian emergency departments
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Draft report: robot-assisted surgery versus open surgery and laparoscopic surgery: clinical and cost- effectiveness analyses
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Ablation procedures for rhythm control in patients with atrial fibrillation: clinical and cost-effectiveness analyses
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Policy guidance on hip protectors in long-term care
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Triple therapy for moderate-to-severe chronic obstructive pulmonary disease
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Clopidogrel compared with other antiplatelet agents for secondary prevention of vascular events in adults undergoing percutaneous coronary intervention: clinical and cost-effectiveness analyses
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy and cost-effectiveness of a gentamicin-loaded collagen sponge as an adjuvant antibiotic prophylaxis for colorectal surgery
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy, safety and cost of ultrafiltration for the management of acute decompensated heart failure
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Argon beam coagulation in orthopaedic, urological and thoracic surgery at the MUHC: a brief report
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Biologic response modifier agents for adults with rheumatoid arthritis
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Negative Pressure Wound Therapy (NPWT) (Update of Report 19)
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Third-line therapy for patients with type 2 diabetes inadequately controlled with metformin and a sulfonylurea
2010     Medical Advisory Secretariat (MAS) Non-invasive cardiac imaging technologies for the diagnosis of coronary artery disease
2010     Medical Advisory Secretariat (MAS) Single photon emission computed tomography for the diagnosis of coronary artery disease
2010     Medical Advisory Secretariat (MAS) Stress echocardiography for the diagnosis of coronary artery disease
2010     Medical Advisory Secretariat (MAS) Stress echocardiography with contrast for the diagnosis of coronary artery disease
2010     Medical Advisory Secretariat (MAS) 64-slice computed tomographic angiography for the diagnosis of intermediate risk coronary artery disease
2010     Medical Advisory Secretariat (MAS) Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease
2010     Medical Advisory Secretariat (MAS) Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis
2010     Medical Advisory Secretariat (MAS) Percutaneous vertebroplasty for treatment of painful osteoporotic vertebral compression fractures
2010     Medical Advisory Secretariat (MAS) Negative pressure wound therapy: an evidence update
2010     Medical Advisory Secretariat (MAS) Epidermal Growth Factor Receptor Mutation (EGFR) testing for prediction of response to EGFR-targeting Tyrosine Kinase Inhibitor (TKI) drugs in patients with advanced non-small-cell lung cancer : an evidence-based and economic analysis
2010     Medical Advisory Secretariat (MAS) Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis
2010     Medical Advisory Secretariat (MAS) Non-invasive cardiac imaging technologies for the assessment of myocardial viability
2010     Medical Advisory Secretariat (MAS) Neuroimaging for the evaluation of chronic headaches : an evidence-based analysis
2010     Medical Advisory Secretariat (MAS) Balloon kyphoplasty for treatment of painful osteoporotic vertebral compression fractures : an evidence update
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Positron emission tomography for cardiovascular disease: a review of the clinical effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Positron emission tomography (PET) in oncology: a systematic review of clinical effectiveness and indications for use
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Second-line therapy for patients with diabetes inadequately controlled on metformin: a systematic review and cost-effectiveness analysis
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Recombinant activated factor VII for prevention of bleeding unrelated to hemophilia: clinical and economic systematic review
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Chronic fatigue syndrome: state of the evidence and assessment of intervention modalities in Quebec]
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy and cost-effectiveness of a gentamicin-loaded collagen sponge as an adjuvant antibiotic prophylaxis for colorectal surgery
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy, safety and cost of ultrafiltration for the management of acute decompensated heart failure.
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Negative Pressure Wound Therapy (NPWT) Update to Report 19
2010     Medical Advisory Secretariat (MAS) Endovascular Repair of Abdominal Aortic Aneurysms in Low Surgical Risk Patients: rapid review
2010     Medical Advisory Secretariat (MAS) Population-based strategies for smoking cessation
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Pulmonary rehabilitation for chronic obstructive pulmonary disease
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Polymerase chain reaction tests for methicillin-resistant staphylococcus aureus in hospitalized patients: clinical and cost-effectiveness analyses
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Bariatric surgery for severe obesity: systematic review and economic evaluation
2010     Medical Advisory Secretariat (MAS) Non-invasive cardiac imaging technologies for the diagnosis of coronary artery disease: a summary of evidence-based analyses
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacologic-based strategies for smoking cessation
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Early identification of sepsis: a review of the evidence for clinical indicators and guidelines for management
2010     Medical Advisory Secretariat (MAS) Positron emission tomography (PET) for the assessment of myocardial viability
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Epidermal growth factor receptor mutation analysis in advanced non-small cell lung cancer: review of economic evaluations and framework for economic analyses
2010     Medical Advisory Secretariat (MAS) Primary angioplasty and thrombolysis for the treatment of acute ST-segment elevated myocardial infarction : an evidence update
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Hyperbaric oxygen therapy for difficult wound healing: systematic review of clinical effectiveness and cost-effectiveness
2010     Medical Advisory Secretariat (MAS) Magnetic resonance imaging (MRI) for the assessment of myocardial viability
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Self-directed cognitive behavioural therapy for adults with diagnosis of depression: systematic review of clinical effectiveness, cost-effectiveness, and guidelines
2010     Medical Advisory Secretariat (MAS) Stenting for peripheral disease of the lower extremities
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Cannabinoids for the management of neuropathic pain: review of clinical effectiveness
2010     Medical Advisory Secretariat (MAS) Endovascular repair of abdominal aortic aneurysms in low surgical risk patients
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of diuretics for hypertension in patients with reduced renal function: a review of clinical effectiveness, safety, and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Telepathology: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Clopidogrel versus other antiplatelet agents in the secondary prevention of vascular events in adults with cerebrovascular disease: clinical and cost-effectiveness analyses
2009     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Initial staging of oesophageal cancer: systematic review of the performance of diagnostic methods]